MILLROCK TECHNOLOGY APPOINTS TOM HOCHULI AS CEO

KINGSTON, N.Y., Jan. 27, 2026 /PRNewswire/ — Millrock Technology Inc (“Millrock”), a provider of freeze-drying and lyophilization solutions for the life sciences and biopharmaceutical markets, announced today the appointment of Tom Hochuli as Chief Executive Officer. 

Mr. Hochuli brings more than three decades of executive leadership experience across life sciences, medical devices, and biologics manufacturing. He joins Millrock at a pivotal moment in the company’s journey and will play a key role in advancing Millrock’s vision to be the most trusted innovator of advanced lyophilization and processing technologies to pharmaceutical and biotech customers.

“Tom is a proven company builder with a deep understanding of complex manufacturing operations, team development, and mission-critical life sciences end markets,” said Bill Pezza, Executive Chairman for Millrock. “His track record of leading businesses makes him an ideal fit to lead Millrock’s next chapter. We are thrilled to welcome Tom to our leadership team”

Most recently, Mr. Hochuli served as President of a biologics-focused organization delivering cellular materials and end-to-end services to biotechnology and biopharmaceutical customers. In that role, he led a comprehensive operational and strategic transformation, improving financial performance, restructuring workflows, and positioning the organization for long-term sustainability. Earlier in his career, he successfully guided a private equity-backed life sciences manufacturing business through rapid operational scale and strategic exit.

Mr. Hochuli’s background spans senior leadership roles at both growth-oriented and global organizations, including responsibility for GMP manufacturing, supply chain, engineering, quality systems, and regulatory compliance.

“Millrock is a highly differentiated business with strong engineering capabilities, deep application expertise, and a reputation for quality that truly matters to its customers,” said Mr. Hochuli. “I’m excited to work alongside the Millrock team to build on that foundation—investing in people, technology, and operational excellence to support customers as they bring critical therapies to market.”

About Millrock Technology

Millrock Technology Inc. is an innovator of freeze-drying (lyophilization) instrumentation and process development solutions for the pharmaceutical, biotech, and diagnostics industries. Millrock specializes in laboratory, pilot, and production-scale lyophilizers, with advanced process control technologies designed to optimize efficiency, compliance, and scalability. To learn more, please visit www.millrocktech.com.

About Artemis

Headquartered in Boston, MA, Artemis is a specialized private equity firm focused on partnering with differentiated Industrial Tech companies, whose people and products enable a healthier, safer, more connected, and productive world. For more information on Artemis, please visit www.artemislp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/millrock-technology-appoints-tom-hochuli-as-ceo-302671566.html

SOURCE Artemis

Staff

Recent Posts

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the…

1 hour ago

REJUVA FRESH® Unveils Three Cutting-Edge Technologies to Empower Providers with a Competitive Edge in 2026

ELLSWORTH, Maine, Jan. 27, 2026 /PRNewswire/ -- At the start of 2026, forward-thinking providers are…

7 hours ago

Revance Executives to Present at IMCAS World Congress 2026

Jeff Bedard and Conor Gallagher to share insights on aesthetic and therapeutic innovationNASHVILLE, Tenn., Jan.…

7 hours ago

IgniteTech Named Exclusive Presenting Sponsor for Generative AI Expo 2026, the #TECHSUPERSHOW

AUSTIN, Texas, Jan. 27, 2026 /PRNewswire/ -- IgniteTech, the AI-DNA Enterprise Software company, today announced…

7 hours ago

happyactually Announces Dr. Maren Voss as Chief Happiness Officer and Scientific Advisor

SEATTLE, Jan. 27, 2026 /PRNewswire/ -- happyactually today announced the official appointment of Dr. Maren…

7 hours ago